Hosted on MSN1d
JMP Securities Initiates Coverage of Context Therapeutics (CNTX) with Market Outperform Recommendation
Fintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...
Confident Buy Rating for Abivax: Phase 3 Trial Progress and Strategic Adjustments for Obefazimod
BTIG analyst Julian Harrison assigned a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) yesterday and set a price target of ...